Axsome Therapeutics, Inc. (AXSM)
Healthcare • Biotechnology
StockNasdaqGMUnited StatesUS05464T1043
138.21 USD
-4.27% today Updated 13 Nov 2026 16:53
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Axsome Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:53. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
22 Feb 2027
in 101 days · 08:00 · estimate -0.11
Last results
-0.25 vs -0.64 estimated
02 Nov 2026 · Beat +60.9%
Beat the estimate
5 of 12
7 missed · 0 in line
Average surprise
-11.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 22 Feb 2027 08:00 | -0.11 | — | — | Upcoming |
| 02 Nov 2026 07:00 | -0.64 | -0.25 | +60.9% | Beat |
| 10 Aug 2026 07:00 | -0.78 | -0.99 | -26.9% | Miss |
| 04 May 2026 07:00 | -0.86 | -1.26 | -46.0% | Miss |
| 23 Feb 2026 07:00 | -0.73 | -0.56 | +23.6% | Beat |
| 03 Nov 2025 07:00 | -0.90 | -0.94 | -4.2% | Miss |
| 04 Aug 2025 07:00 | -1.09 | -0.97 | +10.8% | Beat |
| 05 May 2025 07:00 | -1.35 | -1.22 | +9.5% | Beat |
| 18 Feb 2025 07:00 | -1.05 | -1.54 | -47.0% | Miss |
| 12 Nov 2024 07:00 | -1.39 | -1.34 | +3.5% | Beat |
| 05 Aug 2024 07:00 | -1.33 | -1.67 | -25.8% | Miss |
| 06 May 2024 07:00 | -1.22 | -1.44 | -17.7% | Miss |
| 20 Feb 2024 07:00 | -1.19 | -2.08 | -74.8% | Miss |
| 06 Nov 2023 07:00 | -1.19 | -1.32 | -10.9% | Miss |
| 07 Aug 2023 07:00 | -1.20 | -1.54 | -28.8% | Miss |
| 09 May 2023 06:00 | -0.72 | -0.26 | +64.1% | Beat |
| 27 Feb 2023 07:00 | -1.14 | -1.41 | -24.1% | Miss |
| 07 Nov 2022 07:00 | -1.10 | -1.07 | +2.8% | Beat |
| 09 Aug 2022 07:00 | -1.12 | -1.06 | +5.0% | Beat |
| 02 May 2022 07:00 | -1.01 | -1.03 | -1.5% | Miss |
| 01 Mar 2022 16:00 | -0.97 | -0.90 | +7.6% | Beat |
| 08 Nov 2021 07:00 | -0.93 | -0.93 | +0.5% | In line |
| 09 Aug 2021 07:00 | -0.88 | -0.86 | +2.1% | Beat |
| 10 May 2021 17:00 | -0.81 | -0.78 | +3.7% | Beat |
| 01 Mar 2021 17:00 | -0.70 | -0.78 | -11.2% | Miss |
| 05 Nov 2020 17:00 | -0.55 | -0.58 | -5.6% | Miss |
| 10 Aug 2020 08:00 | -0.61 | -0.49 | +19.5% | Beat |
| 08 May 2020 16:00 | -0.66 | -0.88 | -33.3% | Miss |
| 12 Mar 2020 07:00 | -0.46 | -0.71 | -53.4% | Miss |
| 07 Nov 2019 07:00 | -0.39 | -0.56 | -42.5% | Miss |
| 08 Aug 2019 07:00 | -0.31 | -0.41 | -30.2% | Miss |
| 09 May 2019 07:00 | -0.30 | -0.32 | -5.8% | Miss |
| 14 Mar 2019 07:00 | -0.30 | -0.32 | -9.1% | Miss |
| 09 Nov 2018 07:00 | -0.28 | -0.31 | -10.7% | Miss |
| 08 Aug 2018 07:00 | -0.27 | -0.32 | -17.1% | Miss |
| 08 May 2018 07:00 | -0.28 | -0.29 | -4.7% | Miss |
| 07 Mar 2018 07:00 | -0.31 | -0.28 | +11.1% | Beat |
| 08 Nov 2017 07:00 | -0.34 | -0.27 | +20.6% | Beat |
| 09 Aug 2017 07:00 | -0.34 | -0.30 | +10.9% | Beat |
| 09 May 2017 07:00 | -0.40 | -0.41 | -3.4% | Miss |
| 07 Mar 2017 16:00 | -0.42 | -0.38 | +8.8% | Beat |
| 14 Nov 2016 16:00 | -0.39 | -0.38 | +2.6% | Beat |
| 09 Aug 2016 16:00 | -0.39 | -0.36 | +7.7% | Beat |
| 11 May 2016 16:00 | -0.28 | -0.31 | -12.7% | Miss |
| 24 Mar 2016 16:00 | -0.22 | -0.11 | +49.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 638.5M | +65.5% | -183.2M | -28.7% | -3.68 | +38.6% | -93.9M |
| 2024 | 385.7M | +42.5% | -287.2M | -74.5% | -5.99 | -13.7% | -128.7M |
| 2023 | 270.6M | +440.8% | -239.2M | -88.4% | -5.27 | -14.6% | -145.7M |
| 2022 | 50M | — | -187.1M | -374.0% | -4.60 | — | -117.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 137.15 | 151.31 | 123.00 | 138.03 | -4.43% | 11,954,911 | |
| Oct 2026 | 184.39 | 185.67 | 131.26 | 144.43 | -21.67% | 21,421,200 | |
| Sep 2026 | 199.71 | 229.62 | 182.10 | 184.39 | -7.12% | 14,635,700 | |
| Aug 2026 | 215.50 | 223.40 | 197.05 | 198.52 | -8.93% | 14,058,100 | |
| Jul 2026 | 244.77 | 252.60 | 217.64 | 217.99 | -10.94% | 16,185,000 | |
| Jun 2026 | 233.50 | 260.19 | 217.15 | 244.77 | +4.39% | 24,144,200 | |
| May 2026 | 207.23 | 238.56 | 198.02 | 234.48 | +12.87% | 16,153,400 | |
| Apr 2026 | 170.48 | 217.00 | 165.17 | 207.75 | +22.91% | 15,066,300 | |
| Mar 2026 | 162.06 | 171.60 | 152.28 | 169.02 | +3.13% | 12,671,800 | |
| Feb 2026 | 184.38 | 190.76 | 160.10 | 163.89 | -11.05% | 11,872,800 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Axsome Therapeutics Tops $1 Billion Revenue Run Rate as AUVELITY Sales Surge (opens in a new tab) MarketBeat · 10 Nov 2026 04:14
- Axsome Therapeutics, Inc. (AXSM) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript (opens in a new tab) SeekingAlpha · 09 Nov 2026 13:40
- Is Axsome Therapeutics (AXSM) Fully Priced Given Its Sales Growth? (opens in a new tab) Simply Wall St. · 07 Nov 2026 05:21
- Axsome Therapeutics (AXSM) Stock Gets Fair Value Trim After Q3 Analyst Revisions (opens in a new tab) Simply Wall St. · 06 Nov 2026 11:13
- Axsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027? (opens in a new tab) Motley Fool · 05 Nov 2026 19:37
- Axsome: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 04 Nov 2026 14:29
- Mizuho Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $272 (opens in a new tab) Benzinga · 04 Nov 2026 08:37
- AXSM Stock Has Slumped Nearly 20% Over The Past Month, But BofA Sees Selloff As Overdone (opens in a new tab) Stocktwits · 03 Nov 2026 17:57
- Axsome Therapeutics Could Achieve Earnings in 2027 Amid Growing Auvelity Revenue, RBC Says (opens in a new tab) MT Newswires · 03 Nov 2026 16:28
- Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $249 (opens in a new tab) Benzinga · 03 Nov 2026 13:21
- UBS Maintains Buy on Axsome Therapeutics, Lowers Price Target to $239 (opens in a new tab) Benzinga · 03 Nov 2026 12:16
- Axsome Therapeutics to Participate in Upcoming Investor Conferences (opens in a new tab) 03 Nov 2026 12:00
- RBC Capital Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $273 (opens in a new tab) Benzinga · 03 Nov 2026 10:53
- Guggenheim Maintains Buy on Axsome Therapeutics, Lowers Price Target to $250 (opens in a new tab) Benzinga · 03 Nov 2026 10:37
- Baird Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $220 (opens in a new tab) Benzinga · 03 Nov 2026 07:38
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 144.37 USD
- Market cap
- 7.6B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow AXSM and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.